Lv31
332 积分 2021-07-21 加入
Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review
5小时前
已完结
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
3天前
已完结
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement
9天前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
9天前
已完结
Evaluation of Oral PROTAC Guidelines: Efflux Ratio Outweighs Chameleonicity Descriptors
9天前
已完结
Can PROTACs truly become oral drugs?
9天前
已完结
Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies
9天前
已完结
Enabling formulations for PROTACs: A line-of-sight to clinic
9天前
已完结
The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)
9天前
已完结
NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
9天前
已完结
皖公网安备34019202002308
